MEIP icon

MEI Pharma
MEIP

Overview Fund Activity

62 hedge funds and large institutions have $18.4M invested in MEI Pharma in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 19 reducing their positions, and 13 closing their positions.

Holders
62
Holders Change
-4
Holders Change %
-6.06%
% of All Funds
1.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
14
Reduced
19
Closed
13
Calls
$309K
Puts
$1K
Net Calls
+$308K
Net Calls Change
-$409K

Top Buyers

1
Acadian Asset Management
1
Acadian Asset Management
Massachusetts
$1.23M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$2.97M
3
Two Sigma Investments
3
Two Sigma Investments
New York
$147K
4
Connor, Clark & Lunn Investment Management (CC&L)
4
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$74K
5
ZIM
5
Zacks Investment Management
Illinois
$42K

Top Sellers

1
E
1
Ergoteles
New York
$0
2
Millennium Management
2
Millennium Management
New York
$280K
3
JPMorgan Chase & Co
3
JPMorgan Chase & Co
New York
$1K
4
Goldman Sachs
4
Goldman Sachs
New York
$6K
5
Charles Schwab
5
Charles Schwab
California
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Royal Bank of Canada
76
Royal Bank of Canada
Ontario, Canada
$0 6 +6 New
HI
77
Hudock Inc
Pennsylvania
$0 100 +100 New
1 2 3
4